✦ LIBER ✦

Structure-based and ligand-based drug design for microsomal prostaglandin E synthase-1 inhibitors

✍ Scribed by Li, Chia-Ling; Chang, Tung-Ti; Sun, Mao-Feng; Chen, Hsin-Yi; Tsai, Fuu-Jen; Fisher, Mark; Chen, Calvin Yu-Chian; Lee, Chun-Lin; Fang, Wen-Chang; Wong, Yung-Hao

Book ID: 120498618
Publisher: Taylor and Francis Group
Year: 2011
Tongue: English
Weight: 416 KB
Volume: 37
Category: Article
ISSN: 0892-7022
DOI: 10.1080/08927022.2010.538054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ligand-based drug design for human endot

Ligand-based drug design for human endothelin converting enzyme-1 inhibitors

✍ Karunakar Tanneeru, Itishri Sahu, Lalitha Guruprasad 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 502 KB

Human Microsomal Prostaglandin E Synthas

Human Microsomal Prostaglandin E Synthase-1 (mPGES-1) Binding with Inhibitors and the Quantitative Structure−Activity Correlation

✍ AbdulHameed, Mohamed Diwan M.; Hamza, Adel; Liu, Junjun; Huang, Xiaoqin; Zhan, C 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 200 KB

Thymidylate synthase inhibition: A struc

Thymidylate synthase inhibition: A structure-based rationale for drug design

✍ M. Paola Costi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

Thymidylate synthase (TS) is a very interesting target in antiproliferative diseases. Its inhibition causes thimineless death of the cells and compounds inhibiting TS are widely used in anticancer therapy. The classical antifolate TS inhibitors are structural analogs of the folate cofactor; they oft

ChemInform Abstract: Human Microsomal Pr

ChemInform Abstract: Human Microsomal Prostaglandin E Synthase-1 (mPGES-1) Binding with Inhibitors and the Quantitative Structure—Activity Correlation.

✍ Mohamed Diwan M. AbdulHameed; Adel Hamza; Junjun Liu; Xiaoqin Huang; Cheng-Guo Z 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 15 KB

Human Microsomal Prostaglandin E Synthas

Human Microsomal Prostaglandin E Synthase-1: PURIFICATION, FUNCTIONAL CHARACTERIZATION, AND PROJECTION STRUCTURE DETERMINATION

✍ Thoren, S.; Weinander, R.; Saha, S.; Jegerschold, C.; Pettersson, P. L.; Samuels 📂 Article 📅 2003 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 842 KB

Structure-based drug design of nonpeptid

Structure-based drug design of nonpeptidic P2 substituents for HIV-1 protease inhibitors

✍ Vincent J. Kalish; John H. Tatlock; Jay F. Davies II; Stephen W. Kaldor; Bruce A 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 290 KB

The cocrystal structures of LY289612 and LY297135 were used as a starting point in the design of nonpeptidic HIV-1 protease inhibitors. This report details the discovery of a series of novel aromatic P2 replacement groups. The 3-hydroxy-2-methyl benzoic acid group, discovered in AG1254, was incorpor